CG Oncology CGON Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's total equity?
- CG Oncology (CGON) reported total equity of $1.09B in Q1 2026.
- How has CG Oncology's total equity changed year-over-year?
- CG Oncology's total equity increased by 54.9% year-over-year, from $704.76M to $1.09B.
- What is the long-term trend for CG Oncology's total equity?
- Over 3 years (2022 to 2025), CG Oncology's total equity has grown at a 113.2% compound annual growth rate (CAGR), from -$77.69M to $752.6M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.